Krabeva 100mg Injection

Krabeva 100mg Injection is an anticancer medicine containing the active ingredient Bevacizumab. This medicine is formulated to prevent tumour growth. It is indicated in combination with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube, or primary peritoneal cancer. Use effective birth control during treatment and for at least six months after the last dose. Krabeva 100mg Injection is not recommended for adolescents and children under 18 years of age. Discuss with your doctor about preservation of ovaries if you are planning for pregnancy in the near future, as this medicine may cause fertility issues in women. It is advisable to avoid breastfeeding your baby as this medicine may interfere with growth and development. Krabeva 100mg Injection is often administered in combination with other chemotherapy agents. Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Krabeva 100mg Injection. Before starting treatment with this medicine, inform your doctor if you have high blood pressure, high blood sugar, stomach disorders, or heart problems. This medicine should not be taken for 28 days before and after surgery as it is associated with poor wound healing and high bleeding complications. It is advised to inform your doctor if you have any dental issues requiring surgery before taking this medicine. If you develop any visual changes or confusion, inform your doctor to prevent complications. Krabeva 100mg Injection price in India is based on the seller and place.

krabeva injection uses is indicated to treat the following conditions: Glioblastoma multiforme (brain cancer) Persistent, recurrent, or metastatic breast cancer Metastatic cervical cancer Advanced kidney cancer Metastatic colorectal cancer Advanced non-small-cell lung cancer Liver Cancer- Hepatocellular carcinoma Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer

Krabeva 100mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers. It produces its action by selectively binding to the protein called vascular endothelial growth factor A (VEGF-A), present in the lining of blood and lymph vessels in the body. It interrupts the interaction of VEGF-A with its receptors. This further inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor. As a result, it slows down the rate of progression of cancer.

Your physician or nurse will administer Krabeva 100mg Injection as an intravenous infusion. The infusion should be given immediately after the dilution.

Krabeva side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Headache Vision changes Confusion Severe allergic reactions High Blood pressure Delayed wound healing following surgery Protein in urine Severe infections Blood clots in arteries and blood vessels of lungs Gut perforation Nosebleeds and bleeding risk Heart problems with an increase in heart rate Mouth sores, dryness Shortness of breath Common: Numbness in hands or feet Weakness and lack of energy Diarrhoea, nausea, vomiting, abdominal pain Constipation Loss of appetite Weight loss Changes in taste and speech Decrease in counts of white blood cells Fever Dry skin Back pain